TRAZIMERA subst sèche 150 mg flac
7680669750015
CH-66975
L01FD01
07.16.1.
Reimbursement limitations:
TRAZIPERJ.01
TRAZIMERA en association avec le pertuzumab (PERJETA) comme traitement adjuvant du cancer du sein
Les …
1 / 3
google
Details
- Product number
- 6697501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: trastuzumabum 150 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 20, saccharum, pro vitro.
Articles (1)
Trazimera 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HIMDK |
|
PRC
|
- | Substance | HIMDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 513.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2019
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 66975
- Drug name
- Trazimera, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- L01FD01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 18/04/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRAZIMERA subst sèche 150 mg flac
- Description (DE)
- TRAZIMERA Trockensub 150 mg Durchstf
- Market launch
- 18/04/2019
- Narcotic (BTM)
- No